Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND EML4, ENSG00000143924, 27436 AND Treatment
9 results:

  • 1. Mutations in Classical Signaling Pathways and Their Functional Impact in Microsatellite Instability High colorectal cancer.
    Shi S; Gong Y; Li X; Ding Y; Song G; Liu H; Zhang Z
    Genet Test Mol Biomarkers; 2023 Mar; 27(3):90-99. PubMed ID: 36989521
    [No Abstract]    [Full Text] [Related]  

  • 2. Oncogenic ALK Fusion in Rare and Aggressive Subtype of colorectal Adenocarcinoma as a Potential Therapeutic Target.
    Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H
    Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ALK and ROS1 overexpression is very rare in colorectal adenocarcinoma.
    Houang M; Toon CW; Clarkson A; Sioson L; de Silva K; Watson N; Singh NR; Chou A; Gill AJ
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):134-8. PubMed ID: 24992173
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients.
    Jiang L; Huang J; Morehouse C; Zhu W; Korolevich S; Sui D; Ge X; Lehmann K; Liu Z; Kiefer C; Czapiga M; Su X; Brohawn P; Gu Y; Higgs BW; Yao Y
    Cancer Genet; 2013; 206(9-10):330-9. PubMed ID: 24200637
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation.
    Chung C; Christianson M
    J Oncol Pharm Pract; 2014 Feb; 20(1):11-28. PubMed ID: 23493335
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.
    Karkouche R; Bachet JB; Sandrini J; Mitry E; Penna C; Côté JF; Blons H; Penault-Llorca F; Rougier P; Saint André JP; Emile JF
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1430-7. PubMed ID: 23114745
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.
    Ong FS; Das K; Wang J; Vakil H; Kuo JZ; Blackwell WL; Lim SW; Goodarzi MO; Bernstein KE; Rotter JI; Grody WW
    Expert Rev Mol Diagn; 2012 Jul; 12(6):593-602. PubMed ID: 22845480
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.
    Yokota K; Sasaki H; Okuda K; Shimizu S; Shitara M; Hikosaka Y; Moriyama S; Yano M; Fujii Y
    Oncol Rep; 2012 Oct; 28(4):1187-92. PubMed ID: 22797671
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.